Chengwei Yang

Chengwei Yang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Stem Cells International
Verified
Journal Article
Open access
PDF file
SLShengchang Luo
Shengchang Luo
JWJianxin Wu
Jianxin Wu
YQYuanyuan Qiu
Yuanyuan Qiu
BXBing Xiao
Bing Xiao
YXYanhai Xi
Yanhai Xi
WWWeiheng Wang
Weiheng Wang
Although bone mesenchymal stem cell (BMSC) transplantation has been applied to the treatment of spinal cord injury (SCI), the effect is unsatisfactory due to the specific microenvironment (inflammation and oxidative stress) in the SCI area, which leads to the low survival rate of transplanted cells. Thus, additional strategies are required to improve the efficacy of transplanted cells in the treatment of SCI. Hydrogen possesses antioxidant and anti-inflammatory properties. However, whether hydrogen can enhance the effect of BMSC transplantation in the treatment of SCI has not yet been reported. This study was aimed at investigating whether hydrogen promotes the therapeutic effect of BMSC transplantation in the treatment of SCI in rats. In vitro, BMSCs were cultured in a normal medium and a hydrogen-rich medium to study the effect of hydrogen on the proliferation and migration of BMSCs. BMSCs were treated with a serum-deprived medium (SDM), and the effects of hydrogen on the apoptosis of BMSCs were studied. In vivo, BMSCs were injected into the rat model of SCI. Hydrogen-rich saline (5ml/kg) and saline (5ml/kg) were given once a day via intraperitoneal injection. Neurological function was evaluated using the Basso, Beattie, and Bresnahan (BBB) and CatWalk gait analyses. Histopathological analysis, oxidative stress, inflammatory factors (TNF-α, IL-1β, and IL-6), and transplanted cell viability were detected at 3 and 28 days after SCI. Hydrogen can significantly enhance BMSC proliferation and migration and tolerance to SDM. Hydrogen and BMSC codelivery can significantly enhance neurological function recovery by improving the transplant cell survival rate and migration. Hydrogen can enhance the migration and proliferation capacity of BMSCs to repair SCI by reducing the inflammatory response and oxidative stress in the injured area. Hydrogen and BMSC codelivery is an effective method to improve BMSC transplantation in the treatment of SCI.

6 August 2021 in World Journal of Clinical Cases
Verified
Journal Article
Open access
HLHua Liu
Hua Liu
TZTao Zhang
Tao Zhang
TQTao Qu
Tao Qu
CYChengwei Yang
Chengwei Yang
SLSongkai Li
Songkai Li
Spinal manipulation therapy (SMT) has been widely used worldwide to treat musculoskeletal diseases, but it can cause serious adverse events. Spinal epidural hematoma (SEH) caused by SMT is a rare emergency that can cause neurological dysfunction. We herein report three cases of SEH after SMT. The first case was a 30-year-old woman who experienced neck pain and numbness in both upper limbs immediately after SMT. Her symptoms persisted after 3 d of conservative treatment, and she was admitted to our hospital. Magnetic resonance imaging (MRI) demonstrated an SEH, extending from C6 to C7. The second case was a 55-year-old man with sudden back pain 1 d after SMT, numbness in both lower limbs, an inability to stand or walk, and difficulty urinating. MRI revealed an SEH, extending from T1 to T3. The third case was a 28-year-old man who suddenly developed symptoms of numbness in both lower limbs 4 h after SMT. He was unable to stand or walk and experienced mild back pain. MRI revealed an SEH, extending from T1 to T2. All three patients underwent surgery after failed conservative treatment. The three cases recovered to ASIA grade E on day 5, 1 wk, and day 10 after surgery, respectively. All patients returned to normal after 3 mo of follow-up. SEH caused by SMT is very rare, and the condition of each patient should be evaluated in full detail before operation. SEH should be diagnosed immediately and actively treated by surgery.

1 August 2025 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
BDBai-Tao Dou
Bai-Tao Dou
MLMeng-Jiao Li
Meng-Jiao Li
YLYan-Ling Li
Yan-Ling Li
DCDan Chen
Dan Chen
CYChengwei Yang
Chengwei Yang
HYHao Yao
Hao Yao
Acute high-altitude illness (AHAI), triggered by hypobaric hypoxia following rapid ascent to high elevations, induces complex pathophysiological responses that may be life-threatening. Recent advances in regenerative medicine have highlighted the therapeutic potential of stem cells in mitigating hypoxia-induced damage. Among them, Mesenchymal stem cells (MSCs), the most extensively investigated, exert therapeutic efficacy through immunomodulation, attenuation of oxidative stress, and enhancement of tissue repair mechanisms. Their paracrine signaling profile facilitates angiogenesis and stabilization of the hypoxic microenvironment. Neural stem cells (NSCs) exhibit robust proliferation and differentiation under hypoxic conditions, offering a novel avenue for the treatment of high-altitude cerebral pathology. Additionally, induced pluripotent stem cells (iPSCs), with their pluripotency and patient-specific derivation, present significant promise for personalized, cell-based interventions. Experimental studies demonstrate that these stem cell types modulate the hypoxic milieu via secretion of cytokines, remodeling of the immune microenvironment, and promotion of neovascularization. Nonetheless, several translational challenges persist, including suboptimal homing efficiency, potential immunogenicity, and uncertain long-term safety profiles in high-altitude settings. Future research should prioritize elucidation of stem cell behavior in hypobaric hypoxia, optimization of delivery systems, and establishment of standardized therapeutic protocols. Rigorous clinical validation through evidence-based approaches will be essential to substantiate safety and efficacy. With continued advances in stem cell biology and translational techniques, stem cell-based therapy is poised to emerge as a viable strategy for the prevention and management of AHAI, provided that its clinical deployment is underpinned by robust scientific evidence.

15 September 2023 in Medicine
Verified
Journal Article
Open access
TZTao Zhang
Tao Zhang
LMLihua Ma
Lihua Ma
HLHua Liu
Hua Liu
CYChengwei Yang
Chengwei Yang
SLSongkai Li
Songkai Li
The aim of this study was to investigate the clinical effect of direct isthmus repair via Wiltse approach and classical approach in the treatment of simple lumbar spondylolysis in young patients. Thirty-three patients with simple lumbar spondylolysis underwent direct isthmic repair via the Wiltse approach (n = 17) or the classical approach (n = 16). The operation time, intraoperative blood loss, postoperative drainage volume, hospital stay, fusion rate, visual analogue scale (VAS), and the Oswestry disability index were evaluated and compared between the 2 groups. The amount of intraoperative blood loss, postoperative drainage volume, and the duration of hospital stay in the Wiltse group were lower than those in the classical group (P < .05). There was no significant difference in Oswestry disability index score between the Wiltse group and the classical group at 3 months, 6 months, and 1 year after operation, but the visual analogue scale score in the Wiltse group was lower than that in the classical group at 6 months after surgery (P < .05). The Wiltse approach was comparable to the classical approach in terms of bone graft fusion time and fusion rate. The Wiltse approach for isthmus repair can achieve the same or even better clinical effect than the classical approach, and the Wiltse approach is more minimally invasive. Pedicle screw-hook internal fixation system combined with autogenous iliac bone graft via Wiltse approach is a feasible, safe, and effective minimally invasive surgical method for the repair of isthmic spondylolysis in young patients.

4 January 2024 in Acta Orthopaedica et Traumatologica Turcica
Verified
Journal Article
Open access
TZTao Zhang
Tao Zhang
SLSongkai Li
Songkai Li
LMLihua Ma
Lihua Ma
HLHua Liu
Hua Liu
CYChengwei Yang
Chengwei Yang
LZLian Zhang
Lian Zhang
Objective: This study aimed to evaluate the effectiveness and feasibility of the posterior-only approach for debridement, interbody fusion, and internal fixation in treating upper thoracic tuberculosis. Methods: This study retrospectively analysed the clinical and radiographic data of 8 patients diagnosed with upper thoracic tuberculosis. All patients underwent posterior approach debridement, interbody fusion, and internal fixation. We conducted pre- and postoperative assessments of the visual analog scale (VAS), Oswestry disability index (ODI) scores, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), ASIA score, and kyphotic Cobb angle. Results: Back pain and lower limb weakness were the most common presenting symptoms. The mean duration of surgery, amount of blood loss, and volume of postoperative drainage were 262.5 ± 43.3 min, 625.0 ± 333.8 mL, and 285.0 ± 118.1 mL, respectively. Patients were followed up for 36 to 48 months. Three months after surgery, there was a significant improvement in VAS and ODI scores, which further improved until the final follow-up. A statistically significant difference was observed between the preoperative and postoperative periods (P < .05). At the final follow-up, lower extremity function had fully returned to normal in all 5 paralyzed patients. The ESR and CRP returned to normal, 18.1 ± 7.3 mm/h and 9.95 ± 5.41 mg/L, respectively, within 3 months postoperatively. There were statistical differences between the preoperative and postoperative periods (P < .05). The average kyphotic correction rate was (71.5 ± 7.3)%, and the average loss of correction angle was (3.5 ± 1.4)°. Intervertebral bone fusion was achieved by all patients within 15 months (mean 8.3 ± 3.2 months) postoperatively. Conclusion: The posterior-only approach seems an effective, safe, and reliable treatment method for upper thoracic tuberculosis, with favourable clinical and radiological outcomes. Level of Evidence: Level IV, Therapeutic study Cite this article as: Zhang T, Li S, Ma L, Liu H, Yang C, Zhang L. Clinical effect of posterior-only approach debridement, intervertebral fusion, and internal fixation for upper thoracic tuberculosis. Acta Orthop Traumatol Turc., 2024;58(4):203-208.

14 May 2026 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
XMXiangrui Mao
Xiangrui Mao
RCRuobing Cheng
Ruobing Cheng
JZJian Zhang
Jian Zhang
YYYuxiang Yao
Yuxiang Yao
NJNan Jiang
Nan Jiang
KZKuihua Zhang
Kuihua Zhang
Electrospun polymer nanofibrous scaffolds have gained considerable interest in biomedical applications due to their ability to mimic the architecture and biological functions of the extracellular matrix (ECM). However, precise control over scaffold degradation is essential for ensuring predictable material behavior and supporting their intended function in tissue engineering. In this study, we develop a series of core–shell nanofibrous scaffolds composed of glycidyl methacrylate-grafted silk fibroin and poly(L-lactide-co-caprolactone) (SFMA/PLCL), incorporating an interlayer of organically modified montmorillonite (OMMT). The introduction of OMMT markedly enhances scaffold hydrophilicity, mechanical robustness, and dimensional stability, while enabling finely tunable degradation kinetics. Increasing OMMT content shifts the degradation mode from surface erosion to bulk degradation by facilitating water penetration and disrupting polymer interactions through exfoliated OMMT nanosheets and the release of quaternary ammonium ions. Moreover, the scaffolds exhibit potent antibacterial activity (>99% inhibition against Staphylococcus aureus), strong anti-biofilm performance (>75% suppression), and long-lasting antibacterial effects, all while maintaining excellent cytocompatibility. These results demonstrate that core–shell nanofibrous scaffolds with an OMMT interlayer represent a promising multifunctional platform for tissue engineering applications.